EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
about
Screening for nasopharyngeal cancerScreening for nasopharyngeal carcinomaORC binding to TRF2 stimulates OriP replicationInhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomesThe EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfoldSerological diagnosis of Epstein-Barr virus infection: Problems and solutionsDiscovery of selective inhibitors against EBNA1 via high throughput in silico virtual screeningAntigen-binding properties of monoclonal antibodies reactive with EBNA1 and use in immunoaffinity chromatographyHuman lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cellsInteraction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance.Epstein-Barr virus latency switch in human B-cells: a physico-chemical model.Transcriptional signature and memory retention of human-induced pluripotent stem cellsTranscription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexesDevelopment of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1.Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin.The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promotersClose but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes.DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirusMinicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma.Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing.Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems.Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.Nuclear import of Epstein-Barr virus nuclear antigen 1 mediated by NPI-1 (Importin alpha5) is up- and down-regulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential.The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.Sulfated small molecules targeting eBV in Burkitt lymphoma: from in silico screening to the evidence of in vitro effect on viral episomal DNA.Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cellsTranscriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.Assessing the functional characteristics of synonymous and nonsynonymous mutation candidates by use of large DNA constructs.Characterization and intracellular trafficking of Epstein-Barr virus BBLF1, a protein involved in virion maturationPathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm?The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells.The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency.Slippery substrates impair function of a bacterial protease ATPase by unbalancing translocation versus exitIdentification and characterization of a new E3 ubiquitin ligase in white spot syndrome virus involved in virus latency.The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species.
P2860
Q24187937-1A7990C3-135A-40ED-8C49-65D63D6C0688Q24239852-A08B9CB1-EACE-4CD2-BB6C-8FE4FEE07AD7Q24294674-63CC97DA-29F9-480D-B675-2EC5BEA21127Q24520598-2AA5DC97-8B28-4E4D-80C4-CBB86EBDE2C8Q24531182-A55BDB19-8992-412F-9C0E-F01C424C62A9Q24673761-F213E4C0-EB84-4533-95BA-FAC9B16F3B5DQ24685733-C993606D-FA38-40FF-89D7-C3A8F3B21216Q26829346-57A6061C-2571-425D-BB7E-763F32D40F67Q28473633-EC764CE6-0FBB-465B-8B42-5B6A284D9D60Q28474869-4B0BF172-2359-4466-BDB4-F3035A31B028Q28656323-1EA7188A-C13C-4C2C-89FD-72464AC9F8E0Q30543103-2ECE6265-483A-4734-B343-A60ED297DE2AQ33296308-5D024E83-2F1C-471A-97FA-CAE0422D0981Q33504601-34DD9D9A-5645-44FD-809B-DBD1D7A8B799Q33656437-BCE542B0-E811-4ED4-89D6-15BDF1E09C70Q33712662-B3522840-AD24-4925-82E9-24FC76EAF58AQ33716529-154B53F5-394D-47A9-B4F5-4F2C614F1938Q33781363-52D3FA73-ABFC-41F7-A5D3-6008146C4299Q33845947-DA5FFE70-FFFD-46A6-8DBE-7738FCBAB286Q33851443-4D65E6E7-4D68-4CD9-ACA7-6F5D9A998C21Q33853499-F087D7A5-8430-4226-BAFF-DFDFD454E621Q33900865-3EB9327C-823D-42B6-8BD7-5B6F5E2A9FB1Q33974768-89BFA13D-B88A-4CFE-BD32-30C8018282B6Q34082799-7116AB44-40C9-4220-87F7-B29693086ACAQ34193804-8C419BE9-CD0B-4D21-B3CF-61255EAB42B1Q34353280-AAA12A02-8D3D-4789-90D9-EDAEE89727BDQ34355092-A7F76AC1-11AC-46FC-90F8-8B3D9B974A5EQ34493991-CE619E04-D696-4CB7-A808-F2ABE3289746Q34563797-8E441179-C401-4021-8E48-F0FCD6E7D078Q35020438-5BE81F36-1CC2-4C38-93DE-72B4272EE8E5Q35080523-25223C77-1D4F-4BA1-94DD-46057F239231Q35691576-BAC89407-0DC1-430E-8B6B-D881A156EF46Q35752514-5CF4292A-A02D-4A50-83F5-B8FC1A9853A0Q36246186-ADD742F7-E148-4E24-9313-65CDFB0FEA2AQ36430423-20A703F3-CEC5-41BB-98B8-934D514DB575Q36499480-E68D5A78-8F4A-423C-A5C7-913219DB3BCCQ36524534-33354CDC-ADF6-4105-92ED-A06913773C9BQ36832564-966E2E83-0D26-4FEC-82BA-9E36F159A3F5Q37040203-7F6D6F0E-2B19-42E0-B066-75DB3A99EB83Q37114836-920FE805-D029-498A-ABB6-CA3AA38BDA17
P2860
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
@ast
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
@en
type
label
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
@ast
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
@en
prefLabel
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
@ast
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
@en
P2860
P1476
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1099-1654(200003/04)10:2<83::AID-RMV262>3.0.CO;2-T
P577
2000-03-01T00:00:00Z